# A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

> **NCT03024255** · PHASE2 · COMPLETED · sponsor: **Botanix Pharmaceuticals** · enrollment: 227 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** BBI-4000 gel, 5%
- **DRUG:** BBI-4000 gel, 10%
- **DRUG:** BBI-4000 gel, 15%
- **DRUG:** Vehicle (Placebo)

## Key facts

- **NCT ID:** NCT03024255
- **Lead sponsor:** Botanix Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-22
- **Primary completion:** 2017-09-19
- **Final completion:** 2017-09-19
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03024255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03024255, "A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03024255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*